Skip to main content
SpringerLink
Log in

B-Type Natriuretic Peptide to Assess Cardiac Function in the Critically Ill

  • Conference paper
Yearbook of Intensive Care and Emergency Medicine 2005

Part of the book series: EN]Yearbook of Intensive Care and Emergency Medicine ((volume 2005))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Sudoch T, Kangawa K, Minamino N (1988) A new natriuretic peptide in porcine brain. Nature 332:78–81

    Article  PubMed  Google Scholar 

  2. Saper CB, Hurley KM, Moga MM, et al (1989) Brain natriuretic peptides: Differential localization of a new family of neuropeptides. Neurosci Lett 96:29–34

    Article  PubMed  Google Scholar 

  3. Hystad ME, Geiran OR, Attramadal H, et al (2001) Regional cardiac expression and concentration of natriuretic peptides in patients with severe chronic heart failure. Acta Physiol Scan 171:395–403

    Article  Google Scholar 

  4. Luchner A, Stevens TL, Borgeson DD, et al (1998) Differential atrial and ventricular expression of myocardial BNP during evolution of heart failure. Am J Physiol 274:H1684–1689

    PubMed  Google Scholar 

  5. Nakagawa O, Ogawa Y, Itoh H, et al (1995) Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an ‘emergency’ cardiac hormone against ventricular overload. J Clin Invest 96:1280–1287

    PubMed  Google Scholar 

  6. Sawada Y, Suda M, Yokoyama H, et al (1997) Stretch-induced hypertrophic growth of cardiocytes and processing of B-type natriuretic peptide are controlled by proprotein-processing endopretease furin. J Biol Chem 272:20545–20554

    Article  PubMed  Google Scholar 

  7. Yasue H, Yoshimura M, Sumida H, et al (1994) Localisation and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 90:195–203

    PubMed  Google Scholar 

  8. Maeda K, Tsutamoto T, Wada A, Hisanaga T, Kinoshita M (1998) Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in pateints with symptomatic left ventricular dysfunction. Am Heart J 135:825–832

    PubMed  Google Scholar 

  9. Suga S, Nakao K, Hosoda K, et al (1992) Receptor selectivity of natriuretic peptide family, ANP, BNP and CNP. Endocrinology 130:229–239

    Article  PubMed  Google Scholar 

  10. Almeida FA, Suzuki M, Scarborough RM, Lewicki JA, Maack T (1989) Clearance function of type C receptor of atrial natriuretic factor in rats. Am J Physiol 256:R469–R475

    PubMed  Google Scholar 

  11. Ikram H, Chan W, Espiner EA, Nicholls MG (1980) Haemodynamic and hormone responses to acute and chronic furosemide therapy in congestive heart failure. Clin Sci 59:443–449

    PubMed  Google Scholar 

  12. Shinbane JS, Wood MA, Jensen N, Ellenbogen KA (1997) Tachycardia-induced cardiomyopathy: a review of animal and clinical studies. J Am Coll Cardiol 29:709–715

    Article  PubMed  Google Scholar 

  13. Tsutamoto T, Wada A, Maeda K, et al (2001) Effect of spironolactone on plasma brain natriuretic peptide and left ventricular modelling in patients with congestive heart failure. J Am Coll Cardiol 37:1228–1233

    Article  PubMed  Google Scholar 

  14. Konstam MA, Kronenberg MW, Rousseau MF, et al, (1993) Effects of the angiotensin converting inhibitor enalapril on the long-term progression of left ventricular dilatation in patients with asymptomatic systolic dysfunction. Circulation 88:2277–2283

    PubMed  Google Scholar 

  15. Groenning BA, Nilsson JC, Sondergaard L, Fritz-Hansen T, Larsson HB, Hildebrandt PR (2000) Antiremodeling effects on the left ventricle during beta-blockade with metaprolol in the treatment of chronic heart failure. J Am Coll Cardiol 36:2072–2080

    Article  PubMed  Google Scholar 

  16. Stevens TL, Burnett JC Jr, Kinoshita M, Matsuda Y, Redfield MM (1995) A functional role for endogenous atrial natriuretic peptide in a canine model of early left ventricular dysfunction. J Clin Invest 95:1101–1108

    PubMed  Google Scholar 

  17. Chen HH, Lainchbury JG, Matsuda Y, Harty GJ, Burnett JC Jr (2001) Endogenous natriuretic peptides participate in renal and humoral actions of acute vasopeptidase inhibition in experimental mild heart failure. Hypertension 38:187–191

    PubMed  Google Scholar 

  18. Abraham WT, Lowes BD, Ferguson DA, et al (1998) Systemic haemodynamic, neurohormonal, and renal effects of a steady-state infusion of human brain natriuretic peptide in patients with haemodynamically decompensated heart failure. J Card Fail 4:37–44

    Article  PubMed  Google Scholar 

  19. Brunner-La Rocca HP, Kaye DM, Woods RL, Hastings J, Esler MD (2001) Effects of intravenous brain natriuretic peptide on regional sympathetic activity in patients with chronic heart failure as compared with healthy control subjects. J Am Coll Cardiol 37:1221–1227

    Article  PubMed  Google Scholar 

  20. Okumura K, Yasue H, Fujii H, et al (1995) Effects of brain (B-type) natriuretic peptide on coronary artery diameter and coronary hemodynamic variables in humans: comparison with effects on systemic hemodynamic variables. J Am Coll Cardiol 25:342–348

    Article  PubMed  Google Scholar 

  21. Cowie MR, Struthers AD, Wood DA, et al (1997) Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet 350:1349–1353

    Article  PubMed  Google Scholar 

  22. Maisel AS, Krishnaswamy P, Nowak RM, et al (2002) Rapid measurement of B-type natriuretic peptide assay in emergency diagnosis of heart failure. N Engl J Med 347:161–167

    Article  PubMed  Google Scholar 

  23. Maisel AS, McCord J, Nowak RM, et al (2003) Bedside B-type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction. Results from the Breathing Not Properly Multinational Study. J Am Coll Cardiol 41:2010–2017

    Article  PubMed  Google Scholar 

  24. McCullough PA, Nowak RM, McCord J, et al (2002) B-type natriuretic peptide and clinical judgement in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational Study. Circulation 106:416–422

    Article  PubMed  Google Scholar 

  25. McLean AS, Tang B, Nalos M, Huang SJ, Stewart DE (2003) Increased B-type natriuretic peptide (BNP) level is a strong predictor for cardiac dysfunction in the intensive care unit patients. Anaesth Intensive Care 31:21–27

    PubMed  Google Scholar 

  26. McLean AS, Huang SJ, Ting I (2004) B-type natriuretic peptide: Is there a place in the critical care setting? Crit Care Shock 7:117–124

    Google Scholar 

  27. McLean AS, Huang SJ, Nalos M, Tang B, Stewart DE (2003) The confounding effects of age, gender, serum creatinine, and electrolyte concentrations on plasma B-type natriuretic peptide concentrations in critically ill patients. Crit Care Med 31:2611–2618

    Article  PubMed  Google Scholar 

  28. Berendes E, Van Aken H, Raufhake C, Schmidt C, Assmann G, Walter M (2001) Differential secretion of atrial and brain natriuretic peptide in critically ill patients. Anesth Analg 93:676–682

    PubMed  Google Scholar 

  29. Gerbes AF, Dagnino L, Nguyen T, Nemer M (1994) Transcription of brain natriuretic peptide and atrial natriuretic peptide genes in human tissues. J Clin Endocrinol Metabol 78:1307–1311

    Article  Google Scholar 

  30. Espiner EA, Leikis R, Ferch RD, et al (2002) The neuro-cardio-endocrine response to acute subarachnoid haemorrhage. Clin Endocrinol 56:629–635

    Article  Google Scholar 

  31. Akiba T, Tachibana K, Togashi K, Hiroe M, Marumo F (1995) Plasma human brain natriuretic peptide in chronic renal failure. Clin Nephrol 44:S61–S64

    PubMed  Google Scholar 

  32. McCullough PA, Sandberg KR (2003) B-type natriuretic peptide and renal disease. Heart Fail Rev 8:355–358

    PubMed  Google Scholar 

  33. Wahl HG, Graf S, Renz H, Fassbinder W (2004) Elimination of the cardiac natriuretic peptides B-type natriuretic peptide (BNP) and N-Terminal proBNP by hemodialysis. Clin Chem 50:1071–1074

    Article  PubMed  Google Scholar 

  34. Luchner A, Burnett JC Jr, Jougasaki M, Hense HW, Riegger GA, Schunkert H (1998) Augmentation of the cardiac natriuretic peptides by beta-receptor antagonism: evidence from a population-based study. J Am Coll Cardiol 32:1839–1844

    Article  PubMed  Google Scholar 

  35. Yosimura M, Yasue H, Tanaka H, et al (1994) Responses of plasma concentrations of A type natriuretic peptide and B type natriuretic peptide to alacepril, an angiotensin-converting enzyme inhibitor, in patients with congestive heart failure. Br Heart J 72:528–533

    PubMed  Google Scholar 

  36. Luchner A, Burnett JC Jr, Jougasaki M, et al (2000) Evaluation of brain natriuretic peptide as marker of left ventricular dysfunction and hypertrophy in the population. J Hypertens 18:1121–1128

    PubMed  Google Scholar 

  37. Fruhwald FM, Fahrleitner A, Watzinger N, et al (1999) Natriuretic peptides in patients with diastolic dysfunction due to idiopathic dilated cardiomyopathy. Eur Heart J 1415–1423

    Google Scholar 

  38. Pfister R, Scholz M, Wielckens K, Erdmann E, Schneider CA (2004) Use of NT-proBNP in routine testing and comparison to BNP. Eur J Heart Failure 6:289–293

    Article  Google Scholar 

  39. Maisel A, Hollander JE, Guss D, et al (2004) Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). J Am Coll Cardiol 44:1328–1333

    Article  PubMed  Google Scholar 

  40. Kruger S, Graf J, Merx MW, et al (2004) Brain natriuretic peptide predicts right heart failure in patients with acute pulmonary embolism. Am Heart J 147:60–65

    Article  PubMed  Google Scholar 

  41. Mair J, Friedl W, Thomas S, Puschendorf B (1999) Natriuretic peptides in assessment of left-ventricular dysfunction. Scan J Clin Lab Invest Suppl 230:132–142

    Google Scholar 

  42. McCullough PA, Omland T, Maisel AS (2003) B-type natriuretic peptide: a diagnostic break-through for clincians. Rev Cardiovasc Med 4:72–80

    PubMed  Google Scholar 

  43. Wu AHB, Smith AC, Mather JF, et al (2003) Biological variation for NT-pro-and B-type natriuretic peptides and implications for therapeutic monitoring of patients with congestive heart failure. Am J Cardiol 92:428–431

    Article  Google Scholar 

Download references

Authors
  1. A.S. McLean
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S.J. Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Intensive Care Erasme Hospital, Free University of Brussels, Route de Lennik 808, B-1070, Brussels, Belgium

    Jean-Louis Vincent (Head) (Head)

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

McLean, A., Huang, S. (2005). B-Type Natriuretic Peptide to Assess Cardiac Function in the Critically Ill. In: Vincent, JL. (eds) Yearbook of Intensive Care and Emergency Medicine 2005. EN]Yearbook of Intensive Care and Emergency Medicine, vol 2005. Springer, New York, NY. https://doi.org/10.1007/0-387-26272-5_15

Download citation

  • DOI: https://doi.org/10.1007/0-387-26272-5_15

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-3-540-23476-0

  • Online ISBN: 978-0-387-26272-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation